Table 3.
Intervention Group | Control Group | Intervention–Control Study | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | Mean (SD) | ||||||||||
Pre | Post | p Value a | Effect Size r b | Pre | Post | p Value a | Effect Size r b | diff. IG | diff. CG | p Value c | Effect Size r b | |
PF | 91.52 (10.38) | 93.97 (10.17) | <0.001 | 0.26 | 96.51 (6.92) | 97.22 (6.79) | 0.056 | 0.19 | 2.45 (8.09) | 0.70 (5.18) | <0.001 | 0.21 |
RP | 91.88 (21.97) | 95.89 (14.07) | 0.030 | 0.12 | 94.15 (18.85) | 97.19 (11.51) | 0.053 | 0.01 | 3.98 (23.09) | 3.28 (17.29) | >0.2 | 0.01 |
BP | 77.15 (21.97) | 81.13 (19.62) | 0.013 | 0.14 | 83.68 (20.61) | 81.76 (17.98) | >0.2 | 0.15 | 4.04 (18.69) | −1.93 (18.55) | 0.01 | 0.16 |
GH | 74.30 (14.88) | 76.47 (14.04) | 0.053 | 0.11 | 77.61 (15.35) | 77.67 (13.41) | >0.2 | 0.08 | 2.17 (12.08) | 0.02 (12.24) | 0.154 | 0.09 |
VT | 62.86 (15.77) | 66.10 (14.67) | <0.001 | 0.19 | 63.74 (17.91) | 63.96 (16.45) | >0.2 | 0.13 | 3.24 (11.88) | 0.23 (13.94) | 0.025 | 0.14 |
SF | 89.56 (15.32) | 93.75 (12.03) | <0.001 | 0.22 | 91.13 (14.70) | 92.63 (13.08) | >0.2 | 0.10 | 4.19 (13.21) | 1.34 (14.57) | 0.080 | 0.11 |
RE | 92.99 (19.26) | 94.30 (19.25) | >0.2 | 0.04 | 95.44 (16.57) | 92.28 (21.44) | 0.090 | 0.13 | 1.27 (22.61) | −3.16 (19.49) | 0.018 | 0.15 |
MH | 76.80 (12.39) | 80.01 (11.85) | <0.001 | 0.23 | 78.02 (14.34) | 78.75 (13.27) | >0.2 | 0.14 | 3.21 (10.27) | 0.72 (10.70) | 0.012 | 0.16 |
PSC | 52.06 (6.19) | 53.22 (5.46) | 0.009 | 0.15 | 54.11 (5.24) | 54.42 (4.18) | >0.2 | 0.09 | 1.20 (5.24) | 0.33 (4.64) | 0.103 | 0.10 |
MSC | 51.84 (6.84) | 53.22 (6.62) | <0.001 | 0.20 | 52.00 (7.37) | 51.75 (7.32) | >0.2 | 0.15 | 1.37 (5.86) | −0.13 (5.59) | 0.008 | 0.17 |
a Wilcoxon test. b Effect size r after Rosenthal: 0.1 “small effect”, 0.3 “moderate effect”, 0.5 “strong effect”. c Wilcoxon–Mann–Whitney U test.